← Leaderboards
Peng Jiang
Rutgers, The State Univ Of N.J.
$7,549,401
Attributed
$8,813,720
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.8M · FY2017–25$5M$3.8M$2.5M$1.3M$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,813,720 · 6
By mechanism
R01$7,955,720 · 4
R21$858,000 · 2
Top collaborators
- Sowmya Yelamanchili4 shared
- Steven W Levison1 shared
Others in their field
Other Emerging Leaders on “Brain”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Susan Abushakra · Alzheon, Inc.$50,765,244
- Susan M Landau · University Of California Berkeley$47,252,026
- Evan Z Macosko · Broad Institute, Inc.$36,871,464
- Greg Yothers · University Of Chicago$35,003,821
- Anthony Philippakis · University Of California Santa Cruz$30,961,549
Research focus
BrainInduced Pluripotent Stem CellTechnologyNeuronsBrain TissueIn VivoCellsCrispr/Cas TechnologyGenesPropertyNerve Stem CellLinkMouse ModelHuman ChromosomesInsightSingle-Cell Rna SequencingSynapsesMacrophageIntellectual Functioning DisabilityMicrogliaNovel TherapeuticsNeural CircuitGenome EditingDown Syndrome
Grant awards (18)
Cerebral organoid and IPSC derived microglia: Modeling of HIV and methamphetamine co-morbidity$520,609
R01 · FY2025 · DA
A Human iPSC-Based Chimeric Mouse Model of Alzheimers Disease in Down Syndrome$540,902
R01 · FY2024 · AG · contact PI
Cerebral organoid and IPSC derived microglia: Modeling of HIV and methamphetamine co-morbidity$495,815
R01 · FY2024 · DA
Understanding Down Syndrome Brain Development Using Human iPSC-Based Mouse Chimeras$404,253
R01 · FY2024 · NS · contact PI
Cerebral organoid and IPSC derived microglia: Modeling of HIV and methamphetamine co-morbidity$531,074
R01 · FY2023 · DA
Cytokine Regulation of Secondary Neural Progenitors$431,750
R21 · FY2023 · HD
Understanding Down Syndrome Brain Development Using Human iPSC-Based Mouse Chimeras$422,621
R01 · FY2023 · NS · contact PI
Cerebral organoid and IPSC derived microglia: Modeling of HIV and methamphetamine co-morbidity$549,391
R01 · FY2022 · DA
Understanding Down Syndrome Brain Development Using Human iPSC-Based Mouse Chimeras$427,036
R01 · FY2022 · NS · contact PI
Novel Functions of OLIG2 in Regulating Human Interneuron Production in Health and Disease$339,063
R01 · FY2022 · NS · contact PI
A Human iPSC-Based Chimeric Mouse Model of Alzheimers Disease in Down Syndrome$2,008,397
R01 · FY2021 · AG · contact PI
Understanding Down Syndrome Brain Development Using Human iPSC-Based Mouse Chimeras$417,600
R01 · FY2021 · NS · contact PI
Novel Functions of OLIG2 in Regulating Human Interneuron Production in Health and Disease$339,063
R01 · FY2021 · NS · contact PI
Novel Functions of OLIG2 in Regulating Human Interneuron Production in Health and Disease$315,382
R01 · FY2020 · NS · contact PI
Novel Functions of OLIG2 in Regulating Human Interneuron Production in Health and Disease$315,382
R01 · FY2019 · NS · contact PI
Novel Functions of OLIG2 in Regulating Human Interneuron Production in Health and Disease$329,132
R01 · FY2018 · NS · contact PI
Developing an Astroglial Model for Down Syndrome$193,750
R21 · FY2018 · HD · contact PI
Developing an Astroglial Model for Down Syndrome$232,500
R21 · FY2017 · HD · contact PI